Cai Lay Veterinary Pharmaceutical JSC (HNX:MKV)

Market Cap	66.00B +36.1%
Revenue (ttm)	153.97B +25.4%
Net Income	14.88B +137.3%
EPS	2,978.26 +137.5%
Shares Out	5.00M
PE Ratio	4.43
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,900
Open	13,000
Previous Close	n/a
Day's Range	13,000 - 13,200
52-Week Range	9,300 - 26,400
Beta	0.50
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 16, 2026

About HNX:MKV

Cai Lay Veterinary Pharmaceutical Joint Stock Company produces and trades in veterinary medicines in Vietnam and Indochina. It offers products for cattle, pigs, chickens and ducks, dogs and cats, shrimp and fish, and other species. The company was formerly known as Cai Lay Livestock and Veterinary Pharmacy Company. Cai Lay Veterinary Pharmaceutical Joint Stock Company was incorporated in 2002 and is headquartered in Cai Lay, Vietnam.

• Industry: Pharmaceutical Preparations
• Founded: 2002
• Employees: 112
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: MKV

Financial Performance

In 2025, HNX:MKV's revenue was 149.79 billion, an increase of 39.94% compared to the previous year's 107.04 billion. Earnings were 16.89 billion, an increase of 130.61%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 29, 2026

Data Sources Report a data error